Primitive neuroectodermal tumors, once grouped under a single name, represent a collection of rare and aggressive brain tumors that are now being reclassified using modern genetic and molecular techniques, revealing a diverse family of cancers that primarily affect children and young adults.

Understanding Primitive Neuroectodermal Tumors

Primitive neuroectodermal tumors, commonly known as PNETs, are a type of cancer that begins in the brain or spinal cord. These tumors develop from cells that were supposed to mature into normal nerve cells during the time before a person was born, but instead remained in an undeveloped, or primitive, state. The term “primitive” simply means these cells never finished developing the way they should have.^[1]

In 2016, medical experts made an important change in how these tumors are classified. The World Health Organization updated its system for naming brain tumors, and as a result, PNET is no longer recognized as a single disease category. Instead, doctors now use specific genetic and molecular characteristics to identify these tumors more precisely. This means that tumors previously called PNETs are now being reclassified into specific types based on their unique genetic features, which helps doctors choose better treatments.^[4]

The group of tumors formerly known as PNETs now includes several distinct diagnoses. These include medulloepithelioma, CNS neuroblastoma, CNS ganglioneuroblastoma, embryonal tumor with multilayered rosettes, and several other specific tumor types. Each of these has its own genetic signature and characteristics. Some have specific genetic changes, such as an amplification of a region called C19MC on chromosome 19.^[1]

All tumors formerly grouped as PNETs are considered grade 4 tumors. This grading system helps doctors understand how aggressive a tumor is. Grade 4 means these tumors are malignant (cancerous) and grow very quickly. They have the ability to spread to other parts of the brain and spinal cord through the fluid that surrounds these structures, called cerebrospinal fluid.^[1]

Epidemiology: Who Gets These Tumors

Primitive neuroectodermal tumors are extremely rare. Because the classification system changed in 2016, gathering accurate statistics about how many people have these tumors has become challenging. The tumors that were previously diagnosed as PNETs can now be reclassified into other tumor types, including some newly described tumors that weren’t recognized before.^[1]

Data collected between 2000 and 2014, before the classification change, showed that an estimated 950 people were living with tumors formerly called PNETs in the United States. However, these numbers need to be interpreted carefully because many of these cases would now be classified differently. Each of the specific tumor types that were once grouped together as PNET is individually very rare.^[1]

These tumors occur more commonly in children than in adults. Most cases are found in infants, children, and young adults. The tumors that were previously classified as PNETs can occur in adults, but they show a clear preference for younger age groups. After leukemia and lymphoma, brain tumors are the most common type of childhood cancer, and these aggressive embryonal tumors represent a significant portion of pediatric brain malignancies.^[9]

For peripheral PNETs, which occur outside the brain and spinal cord, the annual incidence of the broader Ewing family of tumors (which includes these peripheral tumors) from birth to age 20 years provides some context for understanding how rare these conditions are. Peripheral primitive neuroectodermal tumors are exceedingly rare, and their true incidence is likely underreported because recent diagnostic advances have allowed them to be distinguished from other similar-looking tumors.^[2]

Causes of Primitive Neuroectodermal Tumors

The exact cause of primitive neuroectodermal tumors remains unknown. Scientists have not been able to identify a single factor that triggers these tumors to develop. However, research has shown that cancer, in general, is a genetic disease. This means it is caused by changes to genes that control how cells function, grow, and divide.^[1]

These genetic changes can cause cells to grow and divide much faster than normal. In the case of PNETs, something goes wrong with the primitive nerve cells left over from fetal development. Normally, these immature cells either develop into mature neurons or disappear naturally. But in rare instances, these cells fail to mature properly and instead begin to grow out of control, forming a tumor.^[6]

Some PNETs are related to specific genetic changes. Modern genetic testing has revealed that different types of embryonal tumors have specific molecular alterations. For example, some have mutations in genes like SHH (sonic hedgehog) or WNT, while others have amplifications of specific chromosomal regions like C19MC. These discoveries have helped doctors understand that what was once called PNET actually represents several different diseases with different genetic causes.^[4]

PNETs form from the ectoderm, which is the outermost layer of cells in a developing embryo during the very early stages of pregnancy. This layer normally gives rise to the nervous system, skin, and other structures. When cells from this layer fail to develop properly and retain their primitive characteristics, they can potentially form these tumors.^[1]

Risk Factors

One of the most puzzling aspects of primitive neuroectodermal tumors is that researchers have been unable to identify clear risk factors that increase a person’s chances of developing these cancers. Unlike many other types of cancer where age, lifestyle, environmental exposures, or family history play a role, PNETs appear to develop without predictable patterns.^[3]

Studies have shown that these tumors do not appear to have a genetic predisposition in most cases. This means they typically do not run in families. A child whose sibling or parent had a PNET is not at increased risk of developing one. This distinguishes PNETs from many other cancers where family history matters.^[3]

Age is one of the few consistent patterns observed with these tumors. They occur more frequently in children and young adults, particularly those under 25 years of age. The peak incidence appears to be in childhood, though adults can also develop these tumors. The reason why younger individuals are more susceptible remains unclear.^[1]

For peripheral PNETs (those occurring outside the central nervous system), there is a slight male predominance. This means boys and men develop these tumors slightly more often than girls and women. However, this pattern is modest and does not explain much about who will develop these tumors.^[2]

Because no clear risk factors have been identified, there is no way to predict who will develop these tumors or to take preventive measures. This can be frustrating for families seeking explanations, but it also means that nothing specific that parents or patients did caused the tumor to develop.^[3]

Symptoms of Primitive Neuroectodermal Tumors

The symptoms of primitive neuroectodermal tumors vary considerably depending on where in the brain or body the tumor develops. Because these tumors grow quickly and often become quite large, they frequently cause symptoms by pressing on surrounding tissues or blocking the normal flow of cerebrospinal fluid.^[1]

Headaches are one of the most common symptoms, particularly morning headaches that may improve after vomiting. This pattern occurs because these tumors often increase pressure inside the skull, a condition called increased intracranial pressure. The headaches may worsen when lying down and improve when sitting or standing up.^[6]

Nausea and vomiting, especially in the morning, are also frequent symptoms. Like headaches, these occur because of increased pressure in the head. Many parents initially think their child has a stomach illness or the flu, not realizing these symptoms point to a brain problem.^[6]

Seizures can occur if the tumor irritates the brain tissue around it. These may be the first sign of a problem in some children. Seizures can take many forms, from brief staring spells to full-body convulsions, depending on which part of the brain is affected.^[1]

Problems with thinking, memory, or concentration may develop as the tumor grows. Children might struggle in school, have difficulty remembering things, or seem confused. Behavioral changes or personality shifts can also occur, which can be particularly distressing for families who notice their child acting differently than usual.^[1]

Physical symptoms often include weakness or numbness, typically affecting one side of the body. Children might have trouble with coordination, balance, and walking. They may stumble, fall more frequently, or have difficulty with activities that require fine motor control. Vision problems, including blurry vision or double vision, can also develop.^[6]

Unexplained weight loss or weight gain may occur without changes in eating habits. Unusual sleepiness or changes in energy level are also common. Some children become unusually tired and want to sleep more than normal, or they may seem irritable and cranky.^[9]

For tumors that develop in or near the spinal cord, symptoms are different. These can include pain in the back and legs, and problems with bowel or bladder control, known as incontinence. These symptoms reflect the tumor’s effect on the nerves that control these functions.^[1]

Because these tumors tend to be large when discovered, symptoms often develop relatively quickly. The fast-growing nature of these cancers means symptoms may appear over weeks rather than months or years, prompting families to seek medical attention sooner than they might with slower-growing tumors.^[7]

Prevention

Unfortunately, there are no known methods to prevent primitive neuroectodermal tumors. Because scientists have not identified specific risk factors or causes that can be modified, there are no lifestyle changes, dietary modifications, or environmental precautions that have been proven to reduce the risk of developing these tumors.^[3]

Unlike some cancers where screening tests can detect disease early in high-risk individuals, there is no screening program for PNETs. These tumors do not have a pattern of running in families, so routine screening of family members is not recommended or helpful.^[3]

The lack of preventive strategies does not mean families are helpless. The most important action is to be aware of symptoms and seek medical attention promptly if concerning signs develop. Early diagnosis, while it cannot prevent the tumor, can lead to earlier treatment, which may improve outcomes.^[6]

For families with a child who has been diagnosed with a PNET, genetic counseling is sometimes offered, though most cases are not hereditary. This counseling can help families understand that these tumors typically occur sporadically, meaning randomly without a family pattern, and that other children in the family are not at increased risk.^[3]

Pathophysiology: How These Tumors Affect the Body

Primitive neuroectodermal tumors disrupt normal body function in several significant ways. Understanding these mechanisms helps explain why symptoms develop and why these tumors are so dangerous.

These tumors develop from primitive nerve cells that should have matured or disappeared during fetal development. Instead of following their normal developmental pathway into mature neurons, these cells remain in an immature state and begin to grow uncontrollably. The rapid, unregulated growth creates a mass that takes up space in the skull or spinal canal, where there is limited room for expansion.^[6]

When a tumor grows in the brain, it can directly damage surrounding brain tissue by compressing it. Different areas of the brain control different functions—movement, sensation, vision, thinking, personality, and more. When a tumor presses on these areas, the functions they control become impaired. This direct compression explains many of the symptoms patients experience, such as weakness on one side of the body or vision problems.^[6]

Many PNETs occur near or block the ventricles, which are chambers in the brain filled with cerebrospinal fluid. This fluid normally flows through these chambers and around the brain and spinal cord, providing cushioning and removing waste products. When a tumor blocks this flow, fluid builds up, causing a condition called hydrocephalus. The accumulated fluid increases pressure inside the skull, causing headaches, nausea, vomiting, and potentially more serious complications if not treated.^[6]

One particularly dangerous characteristic of PNETs is their tendency to spread through cerebrospinal fluid. Because this fluid circulates throughout the brain and spinal cord, tumor cells can break away from the original tumor and travel to other locations in the central nervous system. This type of spread, called metastasis, means that even if the original tumor is removed, cancer cells may have already seeded new tumors elsewhere in the nervous system. About one-third of patients have tumors that have already spread at the time of diagnosis.^[1]

On imaging scans like MRI, PNETs typically appear as a single mass, most commonly in the cortex, which is the outer layer of the brain. The tumors often “enhance” on scans, meaning they appear brighter when contrast dye is injected. Sometimes fluid-filled spaces called cysts form within the tumor mass. There may be swelling in the tissue surrounding the tumor, reflecting inflammation and damage to nearby brain tissue.^[1]

At the cellular level, these tumors consist of small, round cells with deeply stained nuclei when viewed under a microscope. The cells often show increased mitotic figures, meaning they are dividing rapidly. Some tumors show distinctive patterns called rosettes, where multiple cells group together around a central cell. These microscopic features help pathologists identify the tumor type.^[8]

The molecular and genetic changes driving these tumors are complex. Different types of embryonal tumors have different genetic alterations. Some involve mutations in genes that control cell growth and specialization, such as the SHH (sonic hedgehog) gene or the WNT gene family. Others have amplifications of specific chromosomal regions. These genetic changes disrupt the normal signals that tell cells when to grow, when to stop growing, and when to die, leading to uncontrolled tumor growth.^[4]